Upload
buiduong
View
220
Download
0
Embed Size (px)
Citation preview
1
Alternative Treatments for Alternative Treatments for SuperovulationSuperovulation of Beef and Dairy of Beef and Dairy
Donor CowsDonor Cows
G.A. BG.A. Bóó11, , R.J. MapletoftR.J. Mapletoft22, , and G.P. Adamsand G.P. Adams22
11Instituto de ReproducciInstituto de Reproduccióón Animal Cn Animal Cóórdoba rdoba (IRAC), C(IRAC), Cóórdoba, Argentinardoba, Argentina
22WCVM, University of Saskatchewan, Saskatoon, WCVM, University of Saskatchewan, Saskatoon, SK, SK, CanadaCanada
Need to increase the supply of transferable Need to increase the supply of transferable embryos, but variability is highembryos, but variability is high……
Embryo transfer Embryo transfer -- SuperovulationSuperovulation
2
Approximately 70% of the variability in Approximately 70% of the variability in superovulatorysuperovulatory response can be response can be related to ovarian status at the time of related to ovarian status at the time of gonadotropingonadotropin treatmenttreatment
MonniauxMonniaux et al., 1983et al., 1983
Development of follicles Development of follicles ≥≥4 mm 4 mm in in cattlecattle
22--wavewave
33--wavewave
00 99--1010 2020
OvulationOvulationLuteal phase
00 88--99 22221616
Luteal phase
FSHFSH
FSHFSH
3
SuperovulationSuperovulation and follicular wave and follicular wave dynamicsdynamics
SuperstimulatorySuperstimulatory treatments must be treatments must be initiated at the time of wave emergence initiated at the time of wave emergence to obtain optimal responseto obtain optimal response
Nasser et al., 1993Nasser et al., 1993
SuperstimulatorySuperstimulatory response and response and wave emergencewave emergence
Initiation ofInitiation of No. of FolliclesNo. of Follicles No. ofNo. ofTreatmentTreatment nn (>7mm)(>7mm) OvulationsOvulations
Day Day --11 1111 22.022.0++3.43.4aa 9.59.5++2.32.3bb
Day 0Day 0 77 20.320.3++3.83.8aa 18.418.4++3.43.4aa
Day +1Day +1 66 7.77.7++3.43.4bb 6.76.7++2.22.2bb
Day +2Day +2 66 7.37.3++2.32.3bb 6.56.5++2.32.3bb
abab P<0.05P<0.05Nasser et al., 1993Nasser et al., 1993
4
SuperstimulationSuperstimulation treatment with treatment with pp--FSH (FSH (FolltropinFolltropin––V*)V*)
Day 10 Day 10 –– 80 mg80 mg i.m.i.m. BidBidDay 11 Day 11 –– 60 mg60 mg i.m.i.m. BidBidDay 12 Day 12 –– 40 mg40 mg i.m.i.m. Bid and PGF (AM)Bid and PGF (AM)Day 13 Day 13 –– 20 mg20 mg i.m.i.m. BidBidDay 14 Day 14 -- A.I. (PM)A.I. (PM)Day 15 Day 15 -- A.I. (AM)A.I. (AM)
**Bioniche Animal HealthBioniche Animal Health
5
Synchronization of follicle wave Synchronization of follicle wave emergence for emergence for superstimulationsuperstimulation
Follicular ablationFollicular ablation –– 1.5 days1.5 days(2 largest follicles) (2 largest follicles)
EstradiolEstradiol –– 4 days 4 days (5 mg E(5 mg E--1717ββ oror 2 mg EB or EV plus P4)2 mg EB or EV plus P4)
GnRH/pLHGnRH/pLH –– 2 days 2 days (considerable variability)(considerable variability)
AblationAblation
~ 1.5~ 1.5..daysdays
Waveemergence
Bergfelt et al., 1994
Folli
cle
Siz
e
DaysDays
Synchronization of follicle wave emergence with follicular ablationSynchronization of follicle wave Synchronization of follicle wave
emergence with emergence with follicular ablationfollicular ablation
FSHFSH
6
SuperstimulationSuperstimulation -- Follicle ablationFollicle ablation
Day 0 Day 0 AM AM -- Ablate 2 largest folliclesAblate 2 largest follicles-- Insert CIDR Insert CIDR
Day 1 Day 1 AM AM -- Initiate FSH treatmentsInitiate FSH treatmentsDay 4 Day 4 AM AM -- PGFPGF
PM PM -- PGF & remove CIDRPGF & remove CIDRDay 6Day 6 PM PM -- AIAIDay 7Day 7 AM AM -- AIAIDay 13Day 13 Embryo collectionEmbryo collection
12
10
8
6
4
LHLHProgestin andProgestin andestradiolestradiol--1717ββ
~ 4~ 4..daysdays
WaveWaveemergenceemergence
Bo et al., 1994
Folli
cula
r dia
met
er (
mm
)Fo
llicu
lar d
iam
eter
(m
m)
DaysDays
Synchronization of follicular wave emergencewith progestin + E-17β
Synchronization of follicular wave emergenceSynchronization of follicular wave emergencewith with progestin + Eprogestin + E--1717ββ
FSH
FSH
7
SuperovulationSuperovulation following treatment following treatment with a with a CIDR plus ECIDR plus E--1717ββ/P4/P4
Day 0 Day 0 AMAM -- CIDR + ECIDR + E--1717ββ/P4/P4Day 4 Day 4 AMAM -- Initiate FSH treatmentsInitiate FSH treatmentsDay 6Day 6 AM AM -- PGFPGF
PM PM -- Remove CIDRRemove CIDRDay 8Day 8 AM AM -- estrusestrus
PM PM -- AIAIDay 9Day 9 AM AM -- AIAIDay 15Day 15 Embryo CollectionEmbryo Collection
SuperovulatorySuperovulatory responses and responses and embryo productionembryo production……
Did not differ between ProgestinDid not differ between Progestin--treated cows treated cows superstimulatedsuperstimulated……
4 days after 4 days after estradiolestradiol treatmenttreatment, ,
1 day after 1 day after follicular ablationfollicular ablation or,or,
8 and 12 days after estrus in8 and 12 days after estrus inControl cowsControl cows
8
EstrusDetection
D-0 D-10
FSH (12/12h)
EstrusDet. + AI
D-13 D-0 D-7
PGF2αPGFPGF22αα
EC1. Traditional superstimulation
PGF2αPGFPGF22αα
2. Synchronized follicle wave emergence
EstrusDetection
D-0 D-4
FSH (12/12h)
EstrusDet.+ AI
D-7 D-8 D-15
ECPGF2αPGFPGF22αα
P4E2+P4E2+P4
3. Synchronized follicle wave emergence and ovulation
EstrusDetection
D-0 D-4
FSH (12/12h)
EstrusDetection
D-7 D-8 D-15
ECPGF2αPGFPGF22αα
P4GnRH orLH + AI
E2+P4E2+P4
0102030405060708090
100
48 60 72 84 96 108 120h post PGF
AIAIAIAI
Chesta et al., 2003
Ovulation time in Ovulation time in superstimulatedsuperstimulated donorsdonors
But, cows with high But, cows with high superovulatorysuperovulatory responses ovulated responses ovulated 12 hours earlier than those with lower responses12 hours earlier than those with lower responses
9
Individual Data Individual Data
0%
20%
40%
60%
80%
100%
48 60 72 84 96 108 120
h post PGF
6 ov 37009 ov 13 9 ov 412 ov 1218 ov 2132 ov 3630 ov 6
Chesta et al., 2003
Fixed-time AI protocols for superstimulated donors
PGF2α
2
6
10
14
Day 8Day 7
mm
Day 0 Day 4
EB + P4 LH
P4FSH(4 days; 12/12h)
FSH(4 days; 12/12h)
P4
LH
FTAI
10
ProgestinProgestin
0 0 4 4 6 7 8 9 6 7 8 9 1515
2,5 2,5 mgmg EE--1717ββ50 50 mgmg P4P4
DayDay 6.5 6.5 -- ControlControlPGFPGF AIAI ECEC
FSH 2x4FSH 2x4
Experimental designExperimental design
0 0 4 4 6 7 8 9 6 7 8 9 1515
ProgestinProgestin
DayDay 6.5 6.5 -- GnRHGnRH2,5 2,5 mgmg EE--1717ββ50 50 mgmg P4P4
PGFPGF AIAIGnRHGnRH
ECEC
ProgestinProgestin
0 0 4 4 6 7 8 9 6 7 8 9 1515
2,5 2,5 mgmg EE--1717ββ50 50 mgmg P4P4
DayDay 6.5 6.5 -- ControlControlPGFPGF AIAI ECEC
FSH 2x4FSH 2x4
FSH 2x4FSH 2x4
PGFPGF
Experimental designExperimental design
11
0 0 4 4 6 7 8 9 6 7 8 9 1515
ProgestinProgestin
DayDay 6.5 6.5 -- GnRHGnRH2,5 2,5 mgmg EE--1717ββ50 50 mgmg P4P4
PGFPGF AIAIGnRHGnRH
ECEC
ProgestinProgestin
0 0 4 4 6 7 8 9 6 7 8 9 1515
2,5 2,5 mgmg EE--1717ββ50 50 mgmg P4P4
DayDay 6.5 6.5 -- ControlControlPGFPGF AIAI ECEC
FSH 2x4FSH 2x4
FSH 2x4FSH 2x4
ProgestinProgestin
2,5 2,5 mgmg EE--1717ββ50 50 mgmg P4P4
PGFPGF AIAI
0 0 4 4 6 7 8 9 6 7 8 9 1515
DayDay 7 7 -- ControlControlECEC
FSH 2x4FSH 2x4
Experimental designExperimental design
0 0 4 4 6 7 8 9 6 7 8 9 1515
ProgestinProgestin
DayDay 6.5 6.5 -- GnRHGnRH2,5 2,5 mgmg EE--1717ββ50 50 mgmg P4P4
PGFPGF AIAIGnRHGnRH
ECEC
ProgestinProgestin
0 0 4 4 6 7 8 9 6 7 8 9 1515
2,5 2,5 mgmg EE--1717ββ50 50 mgmg P4P4
DayDay 6.5 6.5 -- ControlControlPGFPGF AIAI ECEC
FSH 2x4FSH 2x4
FSH 2x4FSH 2x4
ProgestinProgestin
2,5 2,5 mgmg EE--1717ββ50 50 mgmg P4P4
PGFPGF AIAIGnRHGnRH
ProgestinProgestin
2,5 2,5 mgmg EE--1717ββ50 50 mgmg P4P4
PGFPGF AIAI
0 0 4 4 6 7 8 9 6 7 8 9 1515
DayDay 7 7 -- ControlControlECEC
0 0 4 4 6 7 8 9 6 7 8 9 1515
DayDay 7 7 -- GnRHGnRHECEC
FSH 2x4FSH 2x4
FSH 2x4FSH 2x4
Experimental designExperimental design
12
Day 6,5. ControlDay 6,5. GnRH
Day 7. ControlDay 7. GnRH
64
74
84
94
104
hour
s
Synchrony of ovulationSynchrony of ovulation
But, there were no differences in But, there were no differences in superovulatorysuperovulatory responses responses or numbers of transferable embryosor numbers of transferable embryos…… Bo et al., 2006Bo et al., 2006
Day 6.5 Day 6.5Day 6.5 Day 6.5 Day 7 Day 7Day 7 Day 7Control Control GnRHGnRH Control Control GnRHGnRH
CIDRCIDR0 4 6 7 8 9 0 4 6 7 8 9 1515
2.5 2.5 mgmg EE--1717ββ50 50 mgmg P4P4
PGFPGF
ControlControlHeatHeat--WatchWatch
AI 12 & 24 h AI 12 & 24 h afterafter estrusestrus EmbryoEmbryoCollectionCollection
CIDRCIDR
pLHpLH (12.5 (12.5 mgmg LutropinLutropin--V)V)AI 12 AI 12 andand 24 h 24 h laterlater
0 4 6 7 8 9 0 4 6 7 8 9 1515
2.5 2.5 mgmg EE--1717ββ50 50 mgmg P4P4
PGFPGF AIAIpLHpLH
FixedFixed--time AI in practicetime AI in practice
Larkin et al., 2006
FSH 2x4FSH 2x4
FSH 2x4FSH 2x4
EmbryoEmbryoCollectionCollection
13
HeatHeat--Watch Watch -- AI 12 & 24 h after estrus, AI 12 & 24 h after estrus, or FTAI 12 and 24 after or FTAI 12 and 24 after pLHpLH
9.69.6ªª11.611.6ªª21.421.4ªª57.357.3ªª(53(53--62)62)
FTAIFTAI(n=10)(n=10)
7.87.8ªª11.011.0ªª28.528.5ªª58.558.5ªª(51(51--69)69)
Heat Heat Watch Watch (n=10)(n=10)
ViableViableTotal Total OvaOva
No. ovulationsNo. ovulationsOvulation Ovulation Time (h)Time (h)(range)(range)
ProtocolProtocol
Larkin et al., 2006
Results Results -- FTAI FTAI vsvs Heat WatchHeat Watch
0123456789
10
n
04:00p.m.
06:00p.m.
08:00p.m.
10:00p.m.
12:00a.m.
02:00a.m.
time
Time of first AI
Control pLH
Larkin et al., 2006
14
ab P<0,05
Grade 1 & 2FertilizedOva/embryosNIntervalHormone
2,7 ± 0,4 a3,5 ± 0,5 a5,0 ± 0,65212 h
4,0 ± 0,5 b5,0 ± 0,6 b6,2 ± 0,84724h
3,6 ± 0,44,6 ± 0,65,9 ± 0,747pLH
3,1 ± 0,53,9 ± 0,65,2 ± 0,752GnRH
Interval from Progestin Removal Interval from Progestin Removal to to GnRHGnRH or or pLHpLH
* P4 * P4 DevicesDevices werewere removed in removed in allall donorsdonors withwith thethelastlast FolltropinFolltropin--V V treatmenttreatment..
Adapted from Chesta et al., 2006.
PGF
P4 device
E2 + P4
D0AM
D7AM
EmbryoCollection
D15AM or PM
FSH
D6AM
D4D4AMAM 12 h
AIpLH
D8D8AM AM oror PMPM 24 h
AI
P4 deviceremoval
Holstein cows Holstein cows -- FTAIFTAI
15
PGF
P4 device
E2 + P4
D0AM
D7AM
EmbryoCollection
D15AM or PM
FSH
D6AM
D4D4AMAM 12 h
AIpLH
D8D8AM AM oror PMPM 24 h
AI
P4 deviceremoval
Holstein cows Holstein cows -- FTAIFTAI
4.74.7±±0.90.9bb5.45.4±±0.90.95.75.7±±1.01.02424Day 8.5Day 8.5XX--P4 deviceP4 device
2.12.1±±0.50.5aa3.33.3±±0.50.53.83.8±±0.70.72424Day 8Day 8
pLHpLH n Total Fertilized Transferablen Total Fertilized Transferable
Bo et al., 2006Bo et al., 2006abab P<0.01P<0.01
5.95.9±±1.31.36.46.4±±1.41.46.56.5±±1.51.51212Day 8.5Day 8.5Day 7.5Day 7.5
GonadotrophinGonadotrophin treatments must be initiated at the time treatments must be initiated at the time of follicular wave emergence to optimize of follicular wave emergence to optimize superovulatorysuperovulatory responseresponse
Synchronization of follicular wave emergence offers Synchronization of follicular wave emergence offers the convenience of initiating FSH treatments quickly the convenience of initiating FSH treatments quickly and at a selfand at a self--appointed timeappointed time……
Without the necessity of estrus detectionWithout the necessity of estrus detectionWithout sacrificing responseWithout sacrificing response
Evidence suggests that these procedures can be Evidence suggests that these procedures can be incorporated into protocols that involve fixedincorporated into protocols that involve fixed--time AI of time AI of donor cows, without sacrificing ova/embryo qualitydonor cows, without sacrificing ova/embryo quality
Summary
16
PGF2α
P4 device
E + P4
D0 D7PM
D5
EC
D15PM
FSH
D6D4 D9AM
IA
pLH or GnRH 24h
D8.5PM
D9PM
IA
P4 deviceremoval
PGF2α
P4 device
E + P4
D0 D8AM
D5
EC
D16AM
FSH
D6D4D4PMPM
D9PM
IA
pLH or GnRH 24h
D9D9AMAM
D10AM
IA
P4 deviceremoval
17
PGF2α
CRESTAR®
EB (2mg)
D0 D7T
PGF2α
D8T
AI
EC
D5 D15M
GnRH 12h
FSH
D6D4 D8M
D9M
AI
XCRESTAR®
CRESTAR®
EB (2mg)
D0 D7T
D8T
AI
EC
D5 D15M
GnRH 12h
FSH
D6D4 D8M
D9M
AI
Retirada doCRESTAR®
0.710.710.810.810.280.288.40 8.40 ±± 1.40 1.40 9.90 9.90 ±± 0.780.78Total Ova/Total Ova/embryosembryos (n)(n)
0.880.880.880.880.030.034.20 4.20 ±± 0.740.746.80 6.80 ±± 0.660.66TransferableTransferable EmbryosEmbryos (n)(n)
0.990.990.430.430.030.033.50 3.50 ±± 0.650.655.90 5.90 ±± 0.710.71FreezableFreezable EmbryosEmbryos (n)(n)
50.050.068.768.7 0.010.01
TratTrat
0.540.540.680.68PercentajePercentaje ofof ViableViable EmbryosEmbryos(%)*(%)*
TratTrat vsvsRepRepRepRep
PPSexedSexedSemenSemen(n=10)(n=10)
NonNon SexedSexedSemenSemen(n=10)(n=10)
BaruselliBaruselli et al., 2007et al., 2007
18
68,7
50.0
34,4
45.0
0
10
20
30
40
50
60
70
Taxa
de
embr
iões
viá
veis
(%)
embriões ♀ e ♂ embriões ♀ ou ♂
Convencional Sexado
(68/99) (42/84) (34/99) (38/84)(68/99) (42/84) (34/99) (38/84)
aa
bb
Total de embriões
BaruselliBaruselli et al., 2007et al., 2007
Repeated superstimulation - E-17ββDay 0 Day 0 -- Insert CIDR Insert CIDR
-- inject 5 mg Einject 5 mg E--1717ββ plus 100 mg P4plus 100 mg P4Day 4 Day 4 -- Initiate FSH treatmentsInitiate FSH treatmentsDay 6 Day 6 -- PGFPGF
-- PGF & remove CIDRPGF & remove CIDRDay 8Day 8 -- AIAIDay 9Day 9 -- AIAIDay 15 Day 15 -- Embryo collection & transferEmbryo collection & transfer
-- PGFPGFDay 22 Day 22 -- Estrus Estrus -- PGFPGFDay 30Day 30 -- Insert CIDR Insert CIDR
-- inject 5 mg Einject 5 mg E--1717ββ plus 100 mg P4plus 100 mg P4
19
34.1134.1130.230.239.239.2Flush intervalFlush interval13421342893893449449Total # 1 collectTotal # 1 collect
8.58.5Traditional 60 dayTraditional 60 dayTransfer/flushTransfer/flush(1038 Donors)(1038 Donors)
8.18.18.68.67.27.2Transfer/FlushTransfer/Flush(IETS #1 & #2)(IETS #1 & #2)
0.930.931.01.00.80.8Avg. # 2/FlushAvg. # 2/Flush7.147.147.67.66.46.4Avg. # 1/FlushAvg. # 1/Flush
3.493.493.93.93.03.0Avg. # of FlushesAvg. # of Flushes1881881181187070# of Flushes# of Flushes535330302323# of Donors# of Donors
PooledPooledRed AngusRed AngusHolsteinHolstein
Repeated Repeated superovulationsuperovulation –– EE--1717ββ
Stables, 2003Stables, 2003
GnRH/pLH(Ovulation?)
~2.0.days
Waveemergence
Martinez et al., 1999
Folli
cle
Size
Days
Follicle wave emergence - GnRH or pLHFollicle wave emergence Follicle wave emergence -- GnRHGnRH or or pLHpLH
FSH
20
The problemThe problem……
GnRHGnRH or or pLHpLH will only synchronize will only synchronize follicle wave emergence if ovulation is follicle wave emergence if ovulation is induced. However,induced. However,……
Day of follicular wave emergence Day of follicular wave emergence following following GnRHGnRH or or pLHpLH
Martinez et al., 1999
DayDay --22 --11 TxTx +1+1 +2+2 +3+3 +4+4 +5+5 +6+6
Day 3Day 3OvOv (14)(14) 1010 11 11 22NoNo (4)(4) 11 22 11
Day 6Day 6OvOv.. (14)(14) 11 1111 22NoNo (4)(4) 33 11
Day 9Day 9OvOv.. (8)(8) 11 77NoNo (10)(10) 22 22 44 11 11
OverallOverallOvOv.. (36)(36) 22 2828 33 11 2 2 NoNo (18)(18) 22 22 44 44 33 22 11
21
FA/EFA/E--1717ββ pLH/GnRHpLH/GnRHnn 5454 5151No. of CLNo. of CL 20.120.1 19.719.7Total ova/embryos Total ova/embryos 8.08.0 4.94.9
(%) (%) (40)(40)aa (25)(25)bb
Fertilized Ova Fertilized Ova 4.54.5 2.62.6(%) (%) (56)(56) (53)(53)
Trans. Trans. EmbEmb.. 3.33.3 2.02.0(%) (%) (41)(41) (41)(41)
SuperovulatorySuperovulatory response in Holstein cows after response in Holstein cows after follicular ablation follicular ablation (FA)(FA)//EE--1717ββ or or pLH/GnRHpLH/GnRH
Mitchell et al., 1998 & Deyo et al., 2001(Combined)
abab (P < 0.05)(P < 0.05)
The dilemmaThe dilemma……
Follicle ablation is not readily accessible or Follicle ablation is not readily accessible or easily done in the fieldeasily done in the field
EstradiolEstradiol is not available in many countriesis not available in many countries
GnRHGnRH or or pLHpLH is still not proven, butis still not proven, but……
22
Days 8Days 8--1313 E17E17ββ E17E17ββ** GnRHGnRH
nn 15651565 663663 5656 9595Total ova/embryosTotal ova/embryos
9.99.9 12.412.4 13.313.3 11.211.2Transferable embryosTransferable embryos
5.4 5.4 6.26.2 5.45.4 5.55.5(%) (%) (54)(54) (50)(50) (41)(41) (50)(50)
SuperovulatorySuperovulatory response response -- Holsteins Holsteins Days 8Days 8--13 or 4 d after E13 or 4 d after E--1717ββ or 2.5 d after or 2.5 d after GnRHGnRH
Steel, unpublished* Last year * Last year –– Sexed semenSexed semen
HinshawHinshaw and Beal, 2007and Beal, 2007
23
PGF2α
CIDR or Cue-Mate
D0 D7AM
D5
EC
D15
FSH
D6D4 D8PM
IA
pLH 24h
D8AM
D9AM
IA
P4 deviceremoval
D2
GnRH orpLH
PGF PGF GnRH PGF
140 28 35 37
14 days 12 days 7 days 2 days
GnRH AI
12 h
Fricke, 2005
Days
Presynch
PresynchronizationPresynchronization may improve response by may improve response by ensuring the presence of an ensuring the presence of an ovulatoryovulatory--sized sized follicle at the time of follicle at the time of GnRHGnRH treatment!!treatment!!
24
AlternativesAlternatives……Disregard wave status Disregard wave status Employ Employ ultrasonographyultrasonography to determine the to determine the emergence of a waveemergence of a waveSuperstimulationSuperstimulation on the first follicle waveon the first follicle waveDownDown--regulate the pituitary glandregulate the pituitary glandSubordinate follicle breakSubordinate follicle break--throughthrough……(recruit a new wave with (recruit a new wave with eCGeCG or FSH at or FSH at random stages of the cycle) random stages of the cycle)
Disregard wave statusDisregard wave statusset-up day VS viable embryos
0123456789
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 C
set-up day
viab
le e
mbr
yos
MacDonald, unpublishedMacDonald, unpublished
25
Singh et al., 2003Singh et al., 2003
UltrasonographyUltrasonography to determine emergence of a to determine emergence of a follicle wave follicle wave –– Follicle numbersFollicle numbers……
Number of follicles at end of Number of follicles at end of superstimulatorysuperstimulatorytreatment correlated to number of follicles treatment correlated to number of follicles recruited into the same or the preceding waverecruited into the same or the preceding wave
Simple U/S test will Simple U/S test will permit:permit:
1.1. Determine FWE, Determine FWE, 2.2. Prediction of likely Prediction of likely
donor response, donor response, 3.3. Selection of high Selection of high
producing donors, producing donors, 4.4. Prediction of Prediction of
recipient needsrecipient needs
SuperstimulationSuperstimulation on the first waveon the first wave(Wave 1 (Wave 1 vsvs Wave 2)Wave 2)
Treatment groupTreatment groupEnd Point * End Point * Wave 1Wave 1 Wave 2Wave 2
No. of heifersNo. of heifers 1919 2121Ovulations (U/S)Ovulations (U/S) 6.66.6++1.01.0 8.28.2++1.71.7No. of CL (slaughter)No. of CL (slaughter) 6.56.5++0.90.9 8.18.1++1.81.8Total ova/embryos Total ova/embryos 5.35.3++0.70.7 5.35.3++0.90.9Fertilized ovaFertilized ova 3.03.0++0.60.6 3.33.3++0.70.7*no significant difference*no significant difference
Adams et al., 1994Adams et al., 1994
26
Superovulation: First follicle wave
Day 0 -EstrusDay 1 -CIDR – Folltropin BidDay 2 -Folltropin BidDay 3 -Folltropin BidDay 4 -Folltropin Bid –Day 5 - Folltropin Bid + PGF – AM and PM
Remove CIDR AMDay 6 - LutropinDay 6 PM AIDay 7 AM AIDay 13 - Embryo Collection
2.52.5±±1.21.22.5 2.5 ±± 1.61.67.07.0±±2.72.7UnfertilizedUnfertilized ovaova
5.15.1±±1.71.7bb5.8 5.8 ±± 1.41.4bb0.0 0.0 ±± 0.00.0aaFreezableFreezable embryosembryos
6.66.6±±2.02.0bb8.0 8.0 ±± 1.81.8bb0.2 0.2 ±± 0.20.2aaTransferableTransferable embryosembryos
9.29.2±±2.32.311.7 11.7 ±± 2.92.98.3 8.3 ±± 2.92.9Total ova/Total ova/embryosembryos
14.5 14.5 ±± 2.52.512.7 12.7 ±± 2.72.715.3 15.3 ±± 4.34.3CLCL
23.023.0±±3.73.718.5 18.5 ±± 4.54.521.521.5±± 6.66.6FolliclesFollicles > 8 mm > 8 mm atat FTAIFTAI
666666NN
EB+P4EB+P4PlusPlus CIDRCIDR
FirstFirst WaveWavePlusPlus CIDRCIDR
FirstFirst WaveWaveNo CIDRNo CIDR
GroupsGroups
(a,b P<0.05)Nasser et al., 2002 (IETS)
SuperstimulationSuperstimulation of the of the first first wavewave
27
CUEMATE
PGF GnRHCUEMATE
FSH
PGF Day 4 PM and Day 5 AM
pLH AI AIEmbryo collect
PGF
D-3 PM D7AMD-13 PM D0 PM D4 PM D5AM D6AM D6 PMD-1 AM D13AM
SuperstimulationSuperstimulation -- First follicular waveFirst follicular waveThe setThe set--upup
Carballo GuerreroCarballo Guerrero and Band Bóó, 2007, 2007
00 1010 1313 1818 2020 2626
GnRH
OvulationOvulation
FSH
CueCue--MateMate
FSH
CueCue--MateMatePGFPGFPGFPGF
28
Superovulatory response in Bonsmara cows and heifers treated with Folltropin-V during the first follicular wave or
4 days after estradiol (Control)
3.8 ± 0.73.3 ± 0.65.0 ± 0.99.1 ± 1.239Heifers
5.1 ± 1.04.3 ± 1.06.7 ± 1.410.7 ± 1.629Cows
3.7 ± 0.83.0 ± 0.65.2 ± 1.18.4 ± 1.434Wave 1
5.1 ± 0.94.5 ± 0.96.3 ± 1.111.0 ± 1.434Control
Grades 1, 2 & 3 embryos
Grades 1 & 2 embryos
Fertilized ova
Total ova and embryos
nMain effects
Means did not differ (P>0.20)Carballo GuerreroCarballo Guerrero and Band Bóó, 2007, 2007
Cue-Mate
PGF2α GnRH
Cue-Mate
FSH
PGF D4 PM and D5 AM
pLH AI AIEmbryo Collection
PGF2α
D-3PM
D7AM
D-8 PM D0 PM D4 PM D5AM
D6AM
D6 PMD-1 AM
D13AM
29
8.2 ± 3.79.4 ± 3.612.9 ± 4.711.0 ± 2.39Control
6.1 ± 3.59.0 ± 3.512.3 ± 3.815.6 ± 2.08First Wave
Transferable embryos
Fertilized ova
Total ova/embryos
CLNGroup
Means did not differ (P > 0.4).Bo et al., 2008
2
4
6
12
1
Folli
cle
s ize
(mm
)
Day 0 2 3 4 5 6
1010
88
FSHFSH
Follicle breakFollicle break--throughthrough
CIDRCIDR
500 IU500 IUeCGeCG
30
2
4
6
12
1
Folli
cle
s ize
(mm
)
Day 0 2 3 4 5 6
1010
88
FSHFSH
Follicle breakFollicle break--throughthrough
CIDRCIDR
500 IU500 IUeCGeCG
FSHFSH
SuperovulatorySuperovulatory response in response in AngusAngus embryo embryo donorsdonors withwith historyhistory ofof poorpoor response response
EffectEffect ofof pretreatmentpretreatment withwith eCGeCG
Total Total FertFert GradesGrades Grades Grades TxTx nn CL CL ova/ova/embemb ovaova 1+21+2 1+2+31+2+3
No No eCGeCG 2626 8.58.5±±1.11.1 3.13.1±±0.70.7 1.51.5±±0.40.4 1.01.0±±0.30.3 1.01.0±±0.20.2
eCGeCG 2626 12.012.0±±1.31.3 7.77.7±±1.51.5 4.44.4±±0.70.7 3.53.5±±0.60.6 3.63.6±±0.60.6
PP--valuevalue 0.0050.005 0.0070.007 0.00050.0005 0.00030.0003 0.00020.0002
Carballo GuerreroCarballo Guerrero et al., 2007et al., 2007
31
2
4
6
12
1
Folli
cle
s ize
(mm
)
Day 0 1 2 3 4 5 6
1010
88
FSH
FSHFSH
Standard treatmentStandard treatment
CIDRCIDR
2
4
6
12
1
Folli
cle
s ize
(mm
)
Day 0 1 2 3 4 5 6
1010
88
FSH
FSHFSH
Follicle breakFollicle break--throughthrough
CIDRCIDR
32
PGF2α
Cue-Mate
D0 D7AM
D5
EC
D15
Folltropin-V
D6D4 D8PM
IA
pLH 24h
D8AM
D9AM
IA
P4 deviceremoval
D2
4.9 ± 1.7(n = 18)
6.1 ± 2.0(n = 15)
10.5 ± 2.3(n = 15)
14.1 ± 1.2(n = 26)
Control
3.6 ± 1.0(n = 16)
4.7 ± 1.1(n = 16)
6.9 ± 1.3(n = 16)
12.3 ±1.1(n = 29)
6-d FSH
Transferable embryos
Fertilized ova
Total ova/embryosCLGroup
Superovulatory response in embryo donorstreated with FSH at random stages of the cycleControl - (for 4 days following EB plus P4 device) 6-d FSH - (for 6 days following P4 device)
33
Repeated Superstimulation without E-17ββDay 0 Day 0 -- Insert CIDRInsert CIDRDay 2 Day 2 -- Initiate FSH preInitiate FSH pre--treatmentstreatmentsDay 4 Day 4 -- Initiate FSH Initiate FSH superstimulatorysuperstimulatory treatmentstreatmentsDay 6Day 6 -- PGFPGF
-- PGF & remove CIDRPGF & remove CIDRDay 8 PM Day 8 PM -- AIAIDay 9 AM Day 9 AM -- AIAIDay 15 Day 15 -- Embryo collection & transferEmbryo collection & transfer
-- PGFPGFDay 22 Day 22 -- Estrus Estrus -- PGFPGFDay 28Day 28 -- Insert CIDR Insert CIDR Day 30Day 30 - Initiate FSH pretreatments
SummarySummaryFSH treatments must be initiated at time of follicle wave FSH treatments must be initiated at time of follicle wave emergence to optimize emergence to optimize superovulatorysuperovulatory responseresponse
Follicle ablation or Follicle ablation or estradiolestradiol will synchronize follicle wave will synchronize follicle wave emergence effectively for emergence effectively for superstimulationsuperstimulation
An effective protocol with An effective protocol with GnRHGnRH may be availablemay be available
SuperstimulationSuperstimulation can be initiated effectively at the time of can be initiated effectively at the time of emergence of the first follicle wave (day of ovulation)emergence of the first follicle wave (day of ovulation)
Follicle breakFollicle break--through has the potential to be used in through has the potential to be used in superstimulationsuperstimulation protocols avoiding the need to synchronize protocols avoiding the need to synchronize follicle wave emergencefollicle wave emergence
34
Photo AlbumPhoto Album
by rjm404by rjm404
Thank youThank you
Muchas Gracias
Clinica do Leite – ESALQ/USP
Uso de sêmen sexado paraSOTF em gado de corte
Projeto em parceria com:• Sexing• Lagoa da Serra• Intervet• Departamento de Reprodução Animal, FMVZ-USP
35
Fixed-time AI protocols for superstimulated Bos indicus donors
PGF2α
2
6
10
14
Day 8Day 7
mm
Day 0 Day 4
EB + P4 LH
P4FSH(4 days; 12/12h)
FSH(4 days; 12/12h)
P4
LH
↑E2 + Estrus behaviour
FTAI
0102030405060708090
0 12 24 36 48 60 72 84 96 108 120Hours after PGF
% o
f ovu
latio
nsP12/LH48P24/LH48P36/LH48
PGF(Day 6 AM)
P4 (24h)
P4 (36h)
FSH (4 Days;12/12h)
P4 (12h)
LH(Day 8 AM)
Distribution of ovulations (indicated in hours after the first PGF) in superstimulated Nelore (Bos indicus) donors treated with progesterone releasing devices (DIB) for 6.5d (P12), 7d (P24) or 7.5d (P36) with LH treatment on Day 8
Ultrasonography (12/12h)
Martins et al., 2005
P12 vs P24 = >0.05P12 vs P36 = <0.05P24 vs P36 = <0.05
36
Grupo sêmen convencional (n=10)
PGF2α
CRESTAR®
BE (2mg)
D0 D7T
PGF2α
D8T
IA
Colheita de
Embrião
D5 D15M
GnRH 12h
FSH
D6D4 D8M
D9M
IA
Retirada doCRESTAR®
Grupo sêmen sexado (n=10)
CRESTAR®
BE (2mg)
D0 D7T
D8T
IA
Colheita de
Embrião
D5 D15M
GnRH 12h
FSH
D6D4 D8M
D9M
IA
Retirada doCRESTAR®
Experimental design1st Replicate 2nd Replicate(35d)
Group P24/LH48
Group P24/LH60
Sêmen sexado(n=5)
Sêmen convencional (n=5)
Sêmen sexado(n=5)
Sêmenconvencional (n=5)
The same sires were used in all replicates
37
Tabela - Taxa de prenhez aos 30 e 60 dias após a transferência de embriões provenientes de inseminação com sêmen convencional e sexado e porcentagem de fêmeas na sexagem fetal.
90,0 (18/20)47,6 (20/42)57,1 (24/42)42Sêmen sexado
52,7 (19/36)52,9 (36/68)57,3 (39/68)68Sêmen convencional
Sexagem fetal (% de fêmeas)
Taxa de prenhez60 dias (%)
Taxa de prenhez30 dias (%)NEmbriões
produzidos